P-glycoprotein

Atlas-legend.png

P-glycoprotein (P-gp), also known as multidrug resistance protein 1 (MDR1) or ATP-binding cassette sub-family B member 1 (ABCB1), is a well-characterized protein that functions as a transmembrane ATPase efflux pump. It plays a crucial role in the pharmacokinetics of many drugs by transporting a wide variety of substrates across cell membranes.

Structure[edit]

P-glycoprotein is a member of the ATP-binding cassette (ABC) transporter family. It consists of two homologous halves, each containing six transmembrane domains and an ATP-binding domain. The transmembrane domains form a pathway through which substrates are transported, while the ATP-binding domains provide the energy required for the transport process through ATP hydrolysis.

Function[edit]

P-glycoprotein is primarily involved in the efflux of xenobiotics and endogenous compounds out of cells. It is expressed in various tissues, including the liver, kidney, intestine, blood-brain barrier, and placenta. By pumping out potentially harmful substances, P-glycoprotein protects tissues from toxic insults and plays a significant role in drug metabolism and drug resistance.

Clinical Significance[edit]

P-glycoprotein is a key player in the phenomenon of multidrug resistance (MDR) in cancer therapy. Overexpression of P-gp in tumor cells can lead to decreased intracellular concentrations of chemotherapeutic agents, rendering them less effective. Inhibitors of P-glycoprotein are being studied as potential adjuvants to improve the efficacy of anticancer drugs.

Additionally, P-glycoprotein affects the absorption, distribution, and excretion of many drugs, influencing their bioavailability and therapeutic index. It is also involved in the blood-brain barrier, limiting the entry of drugs into the central nervous system.

Genetics[edit]

The gene encoding P-glycoprotein is known as ABCB1. Genetic polymorphisms in ABCB1 can affect the expression and function of P-glycoprotein, leading to interindividual variability in drug response and toxicity.

Research and Development[edit]

Ongoing research aims to better understand the structure-function relationship of P-glycoprotein, its role in drug resistance, and the development of inhibitors to modulate its activity. Advances in cryo-electron microscopy and molecular dynamics simulations have provided insights into the conformational changes associated with substrate transport and ATP hydrolysis.

References[edit]

External Links[edit]

This protein-related article is a stub. You can help WikiMD by expanding the page.